Cargando…
Ribonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth
Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human malignancies, particularly Kaposi's Sarcoma (KS), which preferentially arise in immunocompromised patients such as HIV+ subpopulation while still lacking of effective therapeutic options. We recently fou...
Autores principales: | Dai, Lu, Chen, Jungang, Cao, Yueyu, Del Valle, Luis, Qin, Zhiqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277659/ https://www.ncbi.nlm.nih.gov/pubmed/30519356 http://dx.doi.org/10.7150/jca.27437 |
Ejemplares similares
-
Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present
por: Huff, Sarah E., et al.
Publicado: (2022) -
Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma
por: Dai, Lu, et al.
Publicado: (2017) -
Convergent allostery in ribonucleotide reductase
por: Thomas, William C., et al.
Publicado: (2019) -
The periodic table of ribonucleotide reductases
por: Ruskoski, Terry B., et al.
Publicado: (2021) -
The Efficacy of the Ribonucleotide Reductase Inhibitor Didox in Preclinical Models of AML
por: Cook, Guerry J., et al.
Publicado: (2014)